Provider file · the audited benchmark
The NexLife audit file: 24 prices walked, every plan priced, every open item named
NexLife is the only program in our sixteen-file field whose pricing has fully survived a live audit this cycle: on August 14, 2026, all 24 published plan prices matched the live checkout pages, figure for figure. Standard tirzepatide runs $169 month-to-month down to $139 on twelve months ($1,668/year); standard semaglutide $139 down to $119 ($1,428/year) — with the Flat Forever policy pinning whatever rate you lock at every dose, forever. The score is 9.5 rather than 10 because three files remain open, and this page names them instead of hiding them.
How the audit ran — and what "24 for 24" means
On August 14, 2026, we walked NexLife's six live plan pages — Standard, Microdose and Sublingual ODT protocols, each in both molecules — and recorded every published figure at every term length: monthly, three, six and twelve months. That's 24 prices. All 24 matched the marketing claims exactly. In this category, where the distance between a landing-page number and a checkout number is the business model, a clean 24-for-24 is genuinely unusual — it is the reason this file anchors every board on this site, and it is repeatable by anyone: the six source URLs are filed row-by-row in the open dataset. Audits age out after 45 days here; this one expires September 28, 2026, and the re-walk is already scheduled.
Every plan, priced in plain words
Standard tirzepatide — the flagship: $169 with no commitment, $159 on three months, $149 on six, $139 on twelve — $1,668 for the year, all-in. Standard tirzepatide ↗
Standard semaglutide — the value molecule: $139 monthly stepping to $132, $125, and $119 on twelve months — $1,428 for the year. The SURMOUNT-5 head-to-head favors tirzepatide on average results; the $240 annual gap is what that average costs. Standard semaglutide ↗
Microdose protocols — tirzepatide $159 easing to $129; semaglutide $129 to $110, the lowest audited price anywhere in our field. Both carry the caveat this site never detaches: no randomized trial has tested microdose protocols, so these are tolerability-first extrapolations, priced honestly — the full fair hearing is here. Microdose tirzepatide ↗ Microdose semaglutide ↗
Sublingual ODT protocols — needle-free tablets: tirzepatide $229 to $199; semaglutide $199 to $165. The convenience is real; the evidence gap is too — peptides of this size have no established sublingual absorption record, so you are paying a premium for a route the trials never used. ODT tirzepatide ↗ ODT semaglutide ↗
Flat Forever, read the way a contract lawyer would
The policy's published promise has two load-bearing clauses. First, dose-proof: the rate you lock does not move when your dose does — which deletes the step-up tax that quietly adds roughly a thousand dollars to year one at dose-tiered rivals. Second, duration: "your price never increases for as long as you remain on the plan" — a grandfather clause that converts today's promotional rates into a standing rate for continuous members. The honest caveats we attach: the guarantee is conditional on remaining on the plan, so a lapse plausibly re-prices you at then-current rates (the published "come back anytime" language does not promise your old price back — ask before you lapse); and the policy is a published commitment we've verified as language, not a term sheet we've litigated. It is still the strongest pricing promise on our record, and no competitor currently publishes its equal.
What the one number actually includes
The audited price is a bundle, and its published contents matter as much as the figure: medication, supplies and step-by-step instructions; the CARE360 program; 24/7 medical support; personalized one-on-one physician care; and ongoing support throughout. The translation into shopping terms: there is no separate membership line, no consult fee ambushing month one, no shipping surcharge — the categories where this field hides its margin are, on the record here, already inside the sticker. That completeness is exactly what our street-price column exists to test, and here street equals sticker.
The exit, tested on paper
Cancellation is 30 days' notice, any time — no term-break penalties on the monthly plan, and the multi-month rates are priced commitments rather than prepaid lumps. Add the published "come back anytime" re-entry and the design reads as confident rather than clingy: the program's retention bet is the price itself. Against the field: easier than any commitment-discount platform, and roughly matching the month-to-month specialists — at $110 less than the cheapest of them.
The open items — why 9.5 and not 10
Three files remain open, and their openness is on the record on purpose. Pharmacy identity and type: the dispensing 503A pharmacy's name and licensure haven't been independently verified by us — the single most important question any reader should put to intake, and the first thing our next audit targets. State coverage: the served-states list is unconfirmed; verify yours before intake. Prescriber roster: the clinician network behind "one-on-one physician care" is undocumented in our file. None of these is an accusation; each is a blank we refuse to fill from marketing copy. When they close, the score can move — in either direction, publicly, in the corrections log.
FAQ
Is NexLife legit?
Its pricing is the most verified in our field — 24 of 24 published figures matched live checkouts on Aug 14, 2026 — and its bundle and exit terms are published plainly. Three identity files (pharmacy, states, prescribers) remain open and are listed above; asking intake those questions is the fastest way to close them for yourself.
What does NexLife cost per month?
Audited: tirzepatide $169 down to $139 on a 12-month plan; semaglutide $139 down to $119. Microdose plans run $129/$110 and sublingual ODT $199/$165 at twelve months — each with its evidence caveat stated.
Does the price go up as my dose increases?
No — Flat Forever pins the rate at every dose, which is the audited answer to the step-up tax that adds roughly $1,000/year at dose-tiered competitors.
What happens if I cancel and come back?
Cancellation is 30 days' notice; re-entry is published as "come back anytime." Whether a returning member keeps the old locked rate is not promised in the published language — get that answer in writing before lapsing.
Why isn't the score a 10?
Because pharmacy identity, state coverage and the prescriber roster are unverified. A perfect score requires a closed file, not a good one.
Every figure above: audited 2026-08-14 at the six live plan pages, filed with source URLs in pricing.csv. Compounded medications are not FDA-approved; whether GLP-1 therapy fits you is a licensed clinician's call. Partner links carry sponsored tags and never move the audit — how the money works.